Analyst Ratings for Merck (MRK) [Buys]
MRK Rating Summary
MRK Price Target Summary
- Highest: $51.00 (MKM Partners)
- Lowest: $40.00 (Barclays)
- Average: $45.60
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$45.60 (-3.2%)
Avg. $ Target:
$45.60 (-3.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2013 | BofA/Merrill Lynch | Upgrade | Buy (Neutral) |
N/A (N/A) |
42.63 | 47.10 | 10.49% | Details |
| 11/20/2012 | MKM Partners | Upgrade | Buy (Neutral) |
51.00 (N/A) |
43.34 | 47.10 | 8.68% | Details |
| 11/12/2012 | BMO Capital | Upgrade | Outperform (Market Perform) |
50.00 (50.00) |
44.05 | 47.10 | 6.92% | Details |
| 4/26/2012 | Auriga | New Coverage | Buy (N/A) |
47.00 (N/A) |
38.43 | 47.10 | 22.56% | Details |
| 1/24/2012 | ISI Group | New Coverage | Buy (N/A) |
45.00 (N/A) |
38.77 | 47.10 | 21.49% | Details |
| 4/29/2011 | Hapoalim Securities | Upgrade | Buy (N/A) |
N/A (N/A) |
35.98 | 47.10 | 30.91% | Details |
| 1/19/2011 | Wells Fargo » Updated 4/30/2013 |
New Coverage | Outperform (N/A) |
N/A (N/A) |
33.87 | 47.10 | 39.06% | Details |
| 11/30/2010 | Credit Agricole | New Coverage | Buy (N/A) |
N/A (N/A) |
34.79 | 47.10 | 35.38% | Details |
